Skip to main
AVTR

Avantor Inc. (AVTR) Stock Forecast & Price Target

Avantor Inc. (AVTR) Analyst Ratings

Based on 13 analyst ratings
Hold
Strong Buy 0%
Buy 38%
Hold 54%
Sell 8%
Strong Sell 0%

Bulls say

Avantor Inc. has demonstrated significant market share gains, securing over $100 million through contract expansions with major pharmaceutical clients, which could enhance volume and profitability through higher fixed cost absorption. The company operates in a robust healthcare sector and is poised for margin expansion that aligns more closely with industry peers, potentially leading to multiple expansion over time. While the near-term growth estimates remain cautious, a strategic focus on cost reductions exceeding $400 million by 2027 is expected to bolster overall financial performance and support a positive long-term outlook.

Bears say

Avantor Inc. has adjusted its FY25 organic revenue growth forecast downward to a range of -2% to 0%, reflecting ongoing customer-specific challenges in the bioprocessing segment and a revenue decline in the second quarter. In addition, the company's second-quarter organic revenues fell 1% to $1.58 billion, accompanied by adjusted EBITDA margins that were below consensus expectations, signaling weakening operational performance. The company also highlighted significant pressures from major customers in the bioprocess sector, which are expected to impact revenues negatively moving forward, particularly if the purchasing slowdown from smaller biotech firms persists.

Avantor Inc. (AVTR) has been analyzed by 13 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 38% recommend Buy, 54% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Avantor Inc. and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Avantor Inc. (AVTR) Forecast

Analysts have given Avantor Inc. (AVTR) a Hold based on their latest research and market trends.

According to 13 analysts, Avantor Inc. (AVTR) has a Hold consensus rating as of Dec 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.92, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.92, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Avantor Inc. (AVTR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.